D’Hyver DC

Language: Spanish
References: 26
Page: 45-57
PDF size: 310.44 Kb.

ABSTRACT

The endocrine system is in charge of the internal metabolism in such a way that its regulation of the intracellular activity and tissues, organs and systems is responsible for an adequate functioning. Aging affects the different axes in many ways and at variable speeds, making the organism prone to having a control failure.
Environmental factors such as nutrition, exercise, or smoking favor the appearance of pathologies. In this case we are interested in the appearance of Type 2 Diabetes Mellitus, hypothyroidism and hypogonadism that not only alter the functions of our body, but also have a very important impact on people’s quality of life.
The high prevalence of these diseases, especially in the elderly, makes it necessary to review some important points such as the pharmacological management of diabetes, timely identification of hypothyroidism, the knowledge of subclinical hypothyroidism as well as when hypogonadism should be treated in spite of the risks inherent to the use of testosterone in advanced ages.

REFERENCES

1. Lamberts SW. The endocrinology of aging and the brain. Arch Neurol 2002:59(11):1709-11

2. Sanzana G. tratamiento de la diabetes en el paciente mayor. Rev med Clin Condes. 2009;20(5):635-8.

3. Mariotti S, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocr Rev. 1995;16:686.

4. Corpas E, Harman SM, Pineyro MA, et al. Growth hormone (GH)- releasing hormone- (1-29) twice daily reverses the decreases GH and insuline – like growth factor – I in old men. J Clin Endocrinol Metab. 1992;75:530.

5. Mehta R, Del Moral ME, Aguilar-Salinas CA. Epidemiología de la diabetes en el anciano. Revista de Investigación Clínica. 2010;62(4):305-11.

6. Nelson JM, Dufraux K, Cook PF. The relationship between glycemic control and falls in older adults. J Am Geriatr Soc. 2007;55:2041-4.

7. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertensive in the Very Elderly Trial cognitive function assessment (HYVET-COG). Lancet Neurol. 2008;7:683-9.

8. Kirkman MS, Jones Briscoe V, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in Older Adults: A Consensus Report. JAGS 60:2342-2356, 2012

9. Valencia WM, Florez H. Pharmacological treatment of diabetes in older people. Diabetes Obes Metab. 2014;16: 1192-203.

10. Sánchez-Lora FJ, Romero-Saucedo V, Gómez-Huelgas R. Protocolo terapéutico de la diabetes en el anciano con comorbilidades. Medicine. 2016;12(18):1046-50.

11. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: Pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care. 2005;28:2948-61.

12. American Diabetes Association. Standards of medical care in diabetes- 2016. Diabetes Care. 2016;39Suppl1:S81-5. [Consultado 19 marzo 2017]. Disponible en: http://care. diabetesjournals.org/site/misc/2016- Standards-of-Care. pdf

13. Qaseem A, Barry MJ, Humphrey LL, Forciea A. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Ann Intern Med. 2017;166:279-90.

14. Flores A, Moreno L, Vega N, et al. Prevalence of autoinmune thyroiditis and thyroid dysfunction in healthy adult Mexicans with a slightly excessive iodine intake. Nutr Hosp. 2015;32:918-24.

15. McAninch E, Bianco A. The History and Future of Treatment of Hypothyroidism. Ann Intern Med. 2016;164:50-6.

16. Biondi B, Cooper D. The Clinical Significance of Subclinical Thyroid Dysfunction. Endocrine Reviews. 2008:29;76- 131.

17. Laurberg P, Andersen S, Bülow Pedersen I, Carlé A. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging. - 2005;22(1);23-38.

18. Hennessey JV, Esoaillat R. Diagnosis and Management of Subclinical Hypothyroidism in Elderly Adults: A Review of the Literature. JAGS. 2015; 63(8):1163.

19. Morales A, Schulman CC, Tostain J, Wu FCW. Testosterone Deficiency Syndrome (TDS) needs to be named appropriately-the importance of accurate terminology. Eur Urol. 2006;50(3):407-9.

20. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91(11):4335- 43.

21. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49:1239-42.

22. Marberger M, Wilson TH, Rittmaster RS. Low serum testosterone levels are poor predictors of sexual dysfunction. BJU international. 2011;108(2):256-62.

23. Isidori AM, Giannetta E, Gianfrilli D, Greco EA, Bonifacio V, Aversa A, et al. Effects of testosterone on sexual function in men: results of a metaanalysis. Clin Endocrinol. 2005;63(4):381-94.

24. Bolona ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC, et al. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82(1):20-8.

25. Snyder PJ. Testosterone treatment of male hypogonadism. Uptodate. 2017. [Consultado: 04 febrero 2017]. Disponible en: www.uptodate.com.

26. Snyder P.J. Overview of testosterone deficiency in older men. Uptodate. 2017. [Consultado: 04 febrero 2017]. Disponible en: www.uptodate.com.